Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (22555)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 14, 2022 (publication date) through May 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Odenwald MA, Paul S. Viral hepatitis: Past, present, and future. World J Gastroenterol 2022; 28(14): 1405-1429 [PMID: 35582678 DOI: 10.3748/wjg.v28.i14.1405] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i14/1405.htm |
| Number | Citing Articles |
| 1 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 2 |
Ji Chen, Suhui Yu, Zhichao Lang, Yan Jin, Guangyao Zhou, Qiqi Tao, Xiaodong Wang, Jianjian Zheng. Development and validation of a potential biomarker to improve the assessment of liver fibrosis progression in patients with chronic hepatitis B. Journal of Medical Virology 2023; 95(1) doi: 10.1002/jmv.28239
|
| 3 |
Kubasov R.V., Mytsuk M.I., Lenina Y.A., Kubasova E.D., Lupachev V.V.. AN OUTBREAK OF UNKNOWN VIRAL HEPATITIS IN CHILDREN IN 2022. "Medical & pharmaceutical journal "Pulse" 2022; : 55 doi: 10.26787/nydha-2686-6838-2022-24-11-55-60
|
| 4 |
Hannah M. Cranford, Daniel Parras, Patricia D. Jones, Edelise Endemano, Katherine Chung-Bridges, Paulo S. Pinheiro. Chronic Viral Hepatitis Screening Inequities Across Florida Federally Qualified Health Centers. Journal of Racial and Ethnic Health Disparities 2025; doi: 10.1007/s40615-025-02363-3
|
| 5 |
Vinay Narladkar, Aman Agrawal, Sanket S Bakshi, Swarupa Chakole, Aniket G Pathade, Seema Yelne. Unravelling the Interplay: Exploring the Influence of Previous Hepatitis B Virus, Hepatitis A Virus, and Hepatitis E Virus Infections on Non-alcoholic Fatty Liver Disease. Cureus 2023; doi: 10.7759/cureus.44969
|
| 6 |
I. Nezgoda, Y. Demchyshyn. CLINICAL AND LABORATORY FEATURES OF THE COURSE OF CHRONIC VIRAL HEPATITIS B AND C IN CHILDREN OF PODILSKY REGION: POSSIBILITY FOR MODERN MONITORING. Клінічна та профілактична медицина 2023; (3): 81 doi: 10.31612/2616-4868.3(25).2023.11
|
| 7 |
Vicente Soriano, Antonio Aguilera, Rafael Benito, Rocío González‐Díez, Elisenda Miró, Paloma Liendo, Juan Carlos Rodríguez‐Diaz, Teresa Cabezas, Alberto Richart, José Manuel Ramos, Luisa Barea, Carmen Álvarez, Ana Treviño, Félix Gómez‐Gallego, Octavio Corral, Carmen de Mendoza. Susceptibility to hepatitis B virus infection in adults living in Spain. Liver International 2023; 43(5): 1015 doi: 10.1111/liv.15548
|
| 8 |
Jiongming Chen, Lei Wu, Yongsheng Li. FGL1 and FGL2: emerging regulators of liver health and disease. Biomarker Research 2024; 12(1) doi: 10.1186/s40364-024-00601-0
|
| 9 |
Chaoyang Wang, He Sun, Rui Wang, Xiaochun Ma, Yini Sun. FGL2: A new target molecule for coagulation and immune regulation in infectious disease. International Immunopharmacology 2024; 143: 113505 doi: 10.1016/j.intimp.2024.113505
|
| 10 |
Jie-Zuo Huang, Bei-Ning Qiao, Dang-Chi Li, Qiu-Rong Wei, Zi-Jian Zhang. Arginine methylation modification in the malignant progression of benign and malignant liver diseases. iLIVER 2024; 3(4): 100124 doi: 10.1016/j.iliver.2024.100124
|
| 11 |
Giacinto Libertini, Graziamaria Corbi, Olga Shubernetskaya, Klara Komici, Nicola Ferrara. The Essential Revolution of Evolutionary Medicine. Advances in Studies of Aging and Health 2024; 4: 57 doi: 10.1007/978-3-031-84877-3_3
|
| 12 |
Xun Qiu, Hanzhi Xu, Kai Wang, Fengqiang Gao, Xiao Xu, Hong He. P-21 Activated Kinases in Liver Disorders. Cancers 2023; 15(2): 551 doi: 10.3390/cancers15020551
|
| 13 |
Suleyman Uraz, Zeynep Deniz, Esra Yerlikaya Zerdali, Adel Araslanova, Veysel Tahan, Fehmi Tabak, Resat Ozaras. The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review. Journal of Viral Hepatitis 2023; 30(7): 588 doi: 10.1111/jvh.13834
|
| 14 |
Lucie Bernard-Raichon, Ken Cadwell. Immunomodulation by Enteric Viruses.
Annual Review of Virology
2023; 10(1): 477 doi: 10.1146/annurev-virology-111821-112317
|
| 15 |
Qing-Ya Li, Xiaona Yang, Zhi-Zhong Guo, Hafiz Ishfaq Ahmad. [Retracted] Correlation Analysis of Cytochrome P450 SNPs in Hepatitis B‐Caused Cirrhosis Patients. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/9891184
|
| 16 |
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023; 15(1): 214 doi: 10.3390/v15010214
|
| 17 |
Tuyaara G. Danilova, Aytalina S. Golderova, Snezhana S. Sleptsova. Awareness of viral hepatitis among the adult population of the Sakha Republic (Yakutia). Saratov Journal of Medical Scientific Research 2024; 20(4): 470 doi: 10.15275/ssmj470
|
| 18 |
Katalin Dezső, Sándor Paku, Mária‐Manuela Juhász, László Kóbori, Péter Nagy. Evolutionary View of Liver Pathology. Evolutionary Applications 2024; 17(12) doi: 10.1111/eva.70059
|
| 19 |
Yang Hu, Qiao Geng, Lu Wang, Yi Wang, Chuyue Huang, Zhimin Fan, Desong Kong. Research progress and application of liver organoids for disease modeling and regenerative therapy. Journal of Molecular Medicine 2024; 102(7): 859 doi: 10.1007/s00109-024-02455-3
|
| 20 |
Matteo Garcovich, Mattia Paratore, Laura Riccardi, Maria Assunta Zocco, Maria Elena Ainora, Geltrude Mingrone, Antonio Gasbarrini, Maurizio Pompili. Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease. Diagnostics 2023; 13(10): 1743 doi: 10.3390/diagnostics13101743
|
| 21 |
Kuihao Chen, Zhe Gao. Acacetin, a Natural Flavone with Potential in Improving Liver Disease Based on Its Anti-Inflammation, Anti-Cancer, Anti-Infection and Other Effects. Molecules 2024; 29(20): 4872 doi: 10.3390/molecules29204872
|
| 22 |
Marta Paula Pereira Coelho, Pedro Alves Soares Vaz de Castro, Thaís Pontello de Vries, Enrico Antônio Colosimo, Juliana Maria Trindade Bezerra, Gifone Aguiar Rocha, Luciana Diniz Silva. Sarcopenia in chronic viral hepatitis: From concept to clinical relevance. World Journal of Hepatology 2023; 15(5): 649-665 doi: 10.4254/wjh.v15.i5.649
Abstract(909) |
Core Tip(655) |
Full Article(HTML)(3719)
|
Full Article with Cover (PDF)-4076K(162)
|
Full Article (Word)-557K(38)
|
Audio-956K(29)
|
Peer-Review Report-134K(84)
|
Answering Reviewers-75K(89)
|
Supplementary Material-136K(92)
|
Full Article (PDF)-2774K(240)
|
Times Cited (8)
|
Total Visits (8214)
|
Open
|
| 23 |
Elitsa Golkocheva-Markova, Chiydem Ismailova, Ani Kevorkyan, Ralitsa Raycheva, Sashka Zhelyazkova, Stanislav Kotsev, Maria Pishmisheva, Vanya Rangelova, Asya Stoyanova, Viliana Yoncheva, Tencho Tenev, Teodora Gladnishka, Iva Trifonova, Iva Christova, Roumen Dimitrov, Roberto Bruni, Anna Rita Ciccaglione. Age and Gender Trends in the Prevalence of Markers for Hepatitis E Virus Exposure in the Heterogeneous Bulgarian Population. Life 2023; 13(6): 1345 doi: 10.3390/life13061345
|
| 24 |
Francesco Bruno, Paolo Abondio, Rossella Bruno, Leognano Ceraudo, Ersilia Paparazzo, Luigi Citrigno, Donata Luiselli, Amalia C. Bruni, Giuseppe Passarino, Rosanna Colao, Raffaele Maletta, Alberto Montesanto. Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis. Ageing Research Reviews 2023; 91: 102068 doi: 10.1016/j.arr.2023.102068
|
| 25 |
Anna Malyshkina, Alicia Brüggemann, Annette Paschen, Ulf Dittmer. Cytotoxic CD4+ T cells in chronic viral infections and cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1271236
|
| 26 |
David Etoori, Sara Cococcia, Ankur Srivastava, Stuart Flanagan, Grainne Nixon, Satya Bobba, Alex Warner, Karen Sennett, Caroline Sabin, Sarah Morgan, William M. Rosenberg. The Camden and Islington Viral Hepatitis Identification Tool (CIVHIT): Use of a Clinical Database Case‐Finding Tool for Hepatitis B, Hepatitis C and HIV in Primary Care. Journal of Viral Hepatitis 2025; 32(4) doi: 10.1111/jvh.14027
|
| 27 |
Ibrahim Alghamdi, Rahaf Alghamdi, Mohamed Alghamdi, Atheer Alghamdi, Murad Alghamdi, Ziyad Alghamdi, Khalil Alghamdi. Epidemiology of Hepatitis B in Saudi Arabia from 2006 to 2021. Hepatic Medicine: Evidence and Research 2023; : 233 doi: 10.2147/HMER.S438099
|
| 28 |
Rodrigo C. Menezes, Isabella B. B. Ferreira, Gabriela L. Rosier, Klauss Villalva-Serra, Vanessa M. S. Campos, Beatriz B. S. Passos, João Victor S. Argolo, Gabriel C. Santana, Stefania L. Garcia, Hugo N. Pustilnik, Rebeca R. C. Silva, Beatriz Barreto-Duarte, Mariana Araújo-Pereira, Bruno B. Andrade. Grand challenges in major tropical diseases: Part II. Frontiers in Tropical Diseases 2023; 4 doi: 10.3389/fitd.2023.1180606
|
| 29 |
Shijian Feng, Dan Tang, Yichang Wang, Xiang Li, Hui Bao, Chengbing Tang, Xiuju Dong, Xinna Li, Qinxue Yang, Yun Yan, Zhijie Yin, Tiantian Shang, Kaixuan Zheng, Xiaofang Huang, Zuheng Wei, Kunjie Wang, Shiqian Qi. The mechanism of ferroptosis and its related diseases. Molecular Biomedicine 2023; 4(1) doi: 10.1186/s43556-023-00142-2
|
| 30 |
Jijiao Wu, Lin Wen, Xiaolian Liu, Qiuxia Li, Zihao Sun, Chuipeng Liang, Fan Xie, Xiaofang Li. Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis. Phytotherapy Research 2024; 38(12): 5713 doi: 10.1002/ptr.8347
|
| 31 |
Romaric De Manfouo Tuono, Marius Mbiandjeu Tchoumke, Winy Asdrid Djoumeni Tepe, Winnie Ketcha Jeuta, Simon Ngamli Fewou. Plasminogen as a Marker for Assessing Thrombotic Risk During Hepatitis in Cameroon: Case–Control Study. Health Science Reports 2025; 8(4) doi: 10.1002/hsr2.70648
|
| 32 |
Dmitry S. Karpov. CRISPR-Cas Systems and Genome Editing: Beginning the Era of CRISPR/Cas Therapies for Humans. International Journal of Molecular Sciences 2024; 25(10): 5292 doi: 10.3390/ijms25105292
|
| 33 |
Weiping Lyu, Haoming Qin, Qi Li, Dehua Lu, Cheng Shi, Kangchen Zhao, Shengran Zhang, Ruohan Yu, Huiying Zhang, Xiaonan Zhou, Sitian Xia, Liangren Zhang, Xiaoqian Wang, Xiaowei Chi, Zhenming Liu. Novel mechanistic insights – A brand new Era for anti-HBV drugs. European Journal of Medicinal Chemistry 2024; 279: 116854 doi: 10.1016/j.ejmech.2024.116854
|
| 34 |
Siqi Yang, Haijie Hu, Hengchung Kung, Ruiqi Zou, Yushi Dai, Yafei Hu, Tiantian Wang, Tianrun Lv, Jun Yu, Fuyu Li. Organoids: The current status and biomedical applications. MedComm 2023; 4(3) doi: 10.1002/mco2.274
|
| 35 |
晓月 谢. Etiology and Diagnosis and Treatment of Markedly Elevated Transaminases. Advances in Clinical Medicine 2023; 13(10): 16797 doi: 10.12677/ACM.2023.13102352
|
| 36 |
Alam Zeb, Namrah Khan, Fawad Ali Shah, Aziz Ullah, Ho-Ik Choi, Jeong-Su Ryu, Yumi Bae, Han-Joo Maeng, Wondong Kim, Jin-Ki Kim. A review on the nanotechnology-based approaches for managing sexually transmitted infections. Journal of Pharmaceutical Investigation 2024; 54(3): 283 doi: 10.1007/s40005-024-00664-z
|
| 37 |
Greeshma Arya, Ashish Bagwari, Hiteshi Saini, Prachi Thakur, Ciro Rodriguez, Pedro Lezama. Explainable AI for Enhanced Interpretation of Liver Cirrhosis Biomarkers. IEEE Access 2023; 11: 123729 doi: 10.1109/ACCESS.2023.3329759
|
| 38 |
Lujian Zhu, Hongjie Tong, Chao Ren, Kun Chen, Shengnan Luo, Qin Wang, Maodong Guo, Yichen Xu, Minli Hu, Jinyong Fang, Jinxian Xu, Peifei Shi. Inflammation unleashed: The role of pyroptosis in chronic liver diseases. International Immunopharmacology 2024; 141: 113006 doi: 10.1016/j.intimp.2024.113006
|
| 39 |
Maria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, Mar Riveiro-Barciela. Hepatitis E as a trigger for acute-on-chronic liver failure. Clinical and Molecular Hepatology 2025; 31(Suppl): S196 doi: 10.3350/cmh.2024.0758
|
| 40 |
Evgenii Gusev, Alexey Sarapultsev. Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement. International Journal of Molecular Sciences 2024; 25(12): 6389 doi: 10.3390/ijms25126389
|
| 41 |
Sajjadh M. J. Ali, Sanjiv Chopra. The Pharmacist's Expanded Role in Critical Care Medicine. 2025; : 571 doi: 10.1007/978-3-031-77335-8_21
|
| 42 |
Taixiu Liu, Ruirui Chen, Deyun Bu, Zheng Shi, Heng Zhang, Wu Li, Dong Liu. An epidemiological study of hepatitis virus infection in psychiatric patients in East China. BMC Public Health 2025; 25(1) doi: 10.1186/s12889-025-22081-z
|
| 43 |
Ram Aasarey, Kajal Yadav, Brijendra Kumar Kashyap, Sarit Prabha, Pramod Kumar, Anil Kumar, Janne Ruokolainen, Kavindra Kumar Kesari. Role of Immunological Cells in Hepatocellular Carcinoma Disease and Associated Pathways. ACS Pharmacology & Translational Science 2023; 6(12): 1801 doi: 10.1021/acsptsci.3c00216
|
| 44 |
|
| 45 |
Haisong Hou, Liu Liang, Lihong Deng, Wanping Ye, Yuanzhang Wen, Jun Liu. Comparison of Clinical Manifestations and Related Factors of Hepatocellular Carcinoma with Chronic Hepatitis B. International Journal of General Medicine 2024; : 2877 doi: 10.2147/IJGM.S464083
|
| 46 |
Li-Li Ou, Jin-Lian Jiang, Man-Lu Guo, Jin-Hua Wu, Wei-Wei Zhong, Yi-Huai He. Research progress on the roles of complement in liver injury. World Journal of Hepatology 2025; 17(3): 103839 doi: 10.4254/wjh.v17.i3.103839
|
| 47 |
Eva Pernicová. Hepatitis E virus: a pathogen of rising significance. Medicína pro praxi 2023; 20(2): 94 doi: 10.36290/med.2023.014
|
| 48 |
Mohammad Darvishi, Majid Nouri, Rasoul Rahimi, Saeid Heidari-Soureshjani, Seyed Mahmoud Reza Hashemi Rafsanjani. A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma. Current Molecular Medicine 2025; 25(5): 589 doi: 10.2174/0115665240284347240125072555
|
| 49 |
Pin Wan, Pan Pan, Binlian Sun, Yongkui Li. Editorial: The role of inflammasome in viral infection, volume II. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1438310
|
| 50 |
Na Zhao, Xiangyu Guo, Lan Wang, Hongming Zhou, Lei Gong, Ziping Miao, Yijuan Chen, Shuwen Qin, Zhao Yu, Shelan Liu, Supen Wang. Changing spatiotemporal patterns for hepatitis of unspecified aetiology in China, 2004–2021: a population-based surveillance study. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1177965
|
| 51 |
Anna H. Mooney, Sarah L. Draper, Olivia K. Burn, Regan J. Anderson, Benjamin J. Compton, Chingwen Tang, Kathryn J. Farrand, Pietro Di Lucia, Micol Ravà, Valeria Fumagalli, Leonardo Giustini, Elisa Bono, Dale I. Godfrey, William R. Heath, Weiming Yuan, Francis V. Chisari, Luca G. Guidotti, Matteo Iannacone, John Sidney, Alessandro Sette, Shivali A. Gulab, Gavin F. Painter, Ian F. Hermans. Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells. JHEP Reports 2024; 6(5): 101038 doi: 10.1016/j.jhepr.2024.101038
|
| 52 |
Mona M. AbouSamra. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications. Journal of Liposome Research 2024; 34(4): 728 doi: 10.1080/08982104.2024.2377085
|
| 53 |
Humzah Iqbal, Bilal Fazal Mehmood, Aalam Sohal, Marina Roytman. Hepatitis E infection: A review. World Journal of Virology 2023; 12(5): 262-271 doi: 10.5501/wjv.v12.i5.262
Abstract(610) |
Core Tip(657) |
Full Article(HTML)(3416)
|
Full Article with Cover (PDF)-2096K(130)
|
Full Article (Word)-834K(19)
|
Audio-712K(6)
|
Peer-Review Report-179K(157)
|
Answering Reviewers-197K(82)
|
Full Article (PDF)-1875K(296)
|
Full Article (XML)-152K(90)
|
Times Cited (7)
|
Total Visits (7659)
|
Open
|
| 54 |
Jia Li, Chu Xiao, Chunxiang Li, Jie He. Tissue-resident immune cells: from defining characteristics to roles in diseases. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02050-5
|
| 55 |
Yongxin Wang, Kai Liu. Therapeutic potential of oleanolic acid in liver diseases. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(7): 4537 doi: 10.1007/s00210-024-02959-2
|
| 56 |
Sunayana Raya, Sarmila Tandukar, Hari Prasad Kattel, Sangita Sharma, Jatuwat Sangsanont, Kwanrawee Sirikanchana, Huong Thi Thuy Ngo, Jessamine Gail M. Inson, Ma. Luisa D. Enriquez, Zeba F. Alam, Ahmad Soleh Setiyawan, Tjandra Setiadi, Eiji Haramoto. Prevalence of hepatitis A and E viruses in wastewater in Asian countries. Science of The Total Environment 2024; 951: 175473 doi: 10.1016/j.scitotenv.2024.175473
|
| 57 |
Zobair M. Younossi, Leyla de Avila, Andrei Racila, Fatema Nader, James Paik, Linda Henry, Maria Stepanova. Prevalence and predictors of cirrhosis and portal hypertension in the United States. Hepatology 2025; doi: 10.1097/HEP.0000000000001243
|